Future Cardiology

Routine screening for detection of atrial fibrillation?
pp. 213-214(2)
Author: Fitzmaurice, David A

Bulletin Board
pp. 215-218(4)

Alcohol and heart disease: where to next?
pp. 219-225(7)
Author: Mukamal, Kenneth J

Idiopathic ventricular fibrillation associated with J wave and early repolarization: a really benign electrocardiographic sign?
pp. 227-229(3)
Authors: Noda, Takashi; Shimizu, Wataru

Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk
pp. 231-236(6)
Author: Stewart, Ralph AH

Prasugrel: newest antiplatelet agent and its emerging role in management of acute coronary syndrome and percutaneous coronary intervention
pp. 237-246(10)
Authors: Robinson, Antwon; Das, Kanak; Koshy, Santosh KG; Das, Pranab

Update on oral antiplatelet therapy: principles, problems and promises
pp. 247-258(12)
Authors: Grove, Erik L; Kristensen, Steen D

Long-term effect of chronic oral anticoagulation: focus on coronary artery disease
pp. 259-271(13)
Authors: Lotrionte, Marzia; Castagno, Davide; Agostoni, Pierfrancesco; Abbate, Antonio; Sangiorgi, Giuseppe; Sheiban, Imad; Biondi-Zoccai, Giuseppe GL

Chemokines as therapeutic targets for atherosclerotic plaque destabilization and rupture
pp. 273-284(12)
Authors: Daissormont, Isabelle TMN; Kraaijeveld, Adriaan O; Biessen, Erik AL

Platelet interactions as therapeutic targets for prevention of atherothrombosis
pp. 285-296(12)
Authors: Smid, Jan; Braun-Dullaeus, Ruediger; Gawaz, Meinrad; Langer, Harald F

Long-term secondary prevention programs after cardiac rehabilitation for the reduction of future cardiovascular events: focus on regular physical activity
pp. 297-314(18)
Authors: Scrutinio, Domenico; Temporelli, Pier Luigi; Passantino, Andrea; Giannuzzi, Pantaleo

Acknowledgements
pp. 319-319(1)